Skip to main content

Table 3 Self-assessed impact of Clostridioides difficile infection (CDI) on participants’ chronic conditions

From: Perception of quality of life in people experiencing or having experienced a Clostridioides difficile infection: a US population survey

 Current CDI, n (%)Negative impact of CDI, n (%)Past CDI, n (%)Negative impact of CDI, n (%)
(n = 115)(n = 235)
≥ 1 chronic disease51 (44.3%)N/A125 (53.2%)N/A
 Alzheimer’s disease or related disease0 (0%)N/A0 (0%)N/A
 Arthritis13 (11.3%)9 (69.2%)41 (17.4%)24 (58.5%)
 Cancer4 (3.5%)1 (25.0%)6 (2.6%)3 (50.0%)
 COPD and allied conditions5 (4.3%)1 (20.0%)12 (5.1%)3 (25.0%)
 Depression17 (14.8%)12 (70.6%)46 (19.6%)42 (91.3%)
 Diabetes7 (6.1%)1 (14.3%)12 (5.1%)5 (41.7%)
 Heart disease3 (2.6%)1 (33.3%)11 (4.7%)1 (9.1%)
 High blood pressure13 (11.3%)5 (38.5%)40 (17.0%)15 (37.5%)
 IBD11 (9.6%)9 (81.8%)26 (11.1%)23 (88.5%)
 IBS10 (8.7%)8 (80.0%)49 (20.9%)43 (87.8%)
 Osteoporosis6 (5.2%)2 (33.3%)20 (8.5%)8 (40.0%)
 Stroke2 (1.7%)1 (50.0%)3 (1.3%)1 (33.3%)
 Other28 (24.3%)N/A58 (24.7%)N/A
\